Trial Information

Summary: Evaluation of the use of Poxvirus Vaccines to Stimulate P53 Specific Immunity

You have been asked to participate in this research study because you have cancer.  The purpose of this study is to determine if blood and lymph node cells from cancer patients can be stimulated in the laboratory with a vaccine to react with p53, a protein found in tumor cells.  Your participation in this study is expected to last until you have donated your blood or completed your upcoming cancer surgery.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 2, 2008 at 2:51:02 PM